2019
DOI: 10.1016/j.ymben.2018.12.001
|View full text |Cite
|
Sign up to set email alerts
|

aMSGE: advanced multiplex site-specific genome engineering with orthogonal modular recombinases in actinomycetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 49 publications
(29 citation statements)
references
References 62 publications
0
29
0
Order By: Relevance
“…Serine-integrases are functional in a wide array of eukaryotes, archaea, and bacteria [28][29][30][31][32][33]35,36,40,59 -so SAGE should work in any transformable bacterium where two conditions are met: att sites are integrated into the genome (Fig. 1) and active serine integrases are expressed.…”
Section: Sage Enables Efficient Genome Engineering In Diverse Bacteriamentioning
confidence: 99%
See 2 more Smart Citations
“…Serine-integrases are functional in a wide array of eukaryotes, archaea, and bacteria [28][29][30][31][32][33]35,36,40,59 -so SAGE should work in any transformable bacterium where two conditions are met: att sites are integrated into the genome (Fig. 1) and active serine integrases are expressed.…”
Section: Sage Enables Efficient Genome Engineering In Diverse Bacteriamentioning
confidence: 99%
“…Homologous recombinationbased allelic exchange relies upon endogenous DNA-repair machinery -which is typically inefficient 27 , precluding the construction of even moderately-sized strain libraries. Integrase-mediated recombination technologies [28][29][30][31][32][33][34][35][36][37] have the potential overcome many of the limitations faced by the above genetic tools. Phage integrases (or site-specific recombinases) are enzymes that catalyze recombination between two specific sequences of DNA 34,38 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition to the in vivo genome engineering, CRISPR/ Cas9 can be utilized for cloning and refactoring of large SM-BGCs [89,[95][96][97][98][99]. Restriction enzymes or PCR-based cloning strategies are not suitable for manipulation of large-sized DNA fragments due to the limited restriction sites and DNA amplification errors.…”
Section: Editing Streptomyces Genomes and Secondary Metabolite Biosynmentioning
confidence: 99%
“…Although genetic tools based on the CRISPR/Cas system have offered diverse strategies to enhance secondary metabolite production and activate silent SM-BGCs [87,89,90,93,99], further optimization of the CRISPR/Cas system for Streptomyces is still required. An example is that the toxicity of Cas nucleases is disadvantageous for multiplexed applications and CRISPR/Cas bearing systems.…”
Section: Future Perspectivementioning
confidence: 99%